Jun 1, 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
A Phase 2 study of metastatic patients previously treated with IV bisphosphonates found that denosumab normalized a key marker of bone resorption at a significantly greater rate than that seen with continuation ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Amgen's help now problem for some | Aug '08 | LadyIsREAL | 2 |
| Biz Buzz: Business briefs for Thursday, July 31... | Jul '08 | Madeline McCann | 1 |
| Is Amgen Hiring? | Jul '08 | The mex | 2 |
| EU Panel Backs Curbing Use Of Anemia Drugs In C... | Jun '08 | gdpawel | 1 |
| Simi Valley man gets two years for embezzling f... | May '08 | love animals | 1 |
| FDA panel gives surprise OK to Amgen and J&J (from Mar '08) | Mar '08 | Treat Cancer | 3 |
| Limits proposed for anemia drugs (from Mar '08) | Mar '08 | Dr Bendover | 4 |
